Neil Bhola, Ph.D.
Affiliations: | 2009 | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Pharmacology, Molecular BiologyGoogle:
"Neil Bhola"Parents
Sign in to add mentorJennifer R. Grandis | grad student | 2009 | University of Pittsburgh | |
(Investigation of the mechanisms and therapeutic implications of crosstalk between G-protein-coupled receptors and the epidermal growth factor receptor in HNSCC.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Brand TM, Hartmann S, Bhola NE, et al. (2022) Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer. Cancer Research. 82: 3187 |
Brand TM, Hartmann S, Bhola NE, et al. (2022) Editor's Note: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer. Cancer Research. 82: 3188 |
Swaney DL, Ramms DJ, Wang Z, et al. (2021) A protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity. Science (New York, N.Y.). 374: eabf2911 |
Bouhaddou M, Lee RH, Li H, et al. (2021) Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer. Jci Insight |
Bhola NE, Njatcha C, Hu L, et al. (2021) PD-L1 is upregulated via BRD2 in head and neck squamous cell carcinoma models of acquired cetuximab resistance. Head & Neck |
Brand TM, Hartmann S, Bhola NE, et al. (2021) Correction: Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 27: 4129 |
O'Keefe RA, Bhola NE, Lee DS, et al. (2020) Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance. Plos One. 15: e0227261 |
Bhola N, Givmanesh A, Wagle M, et al. (2020) Abstract 631: Mat2A Inhibitors decrease growth, increase senescence and p53 stability in MTAP-deleted cancer cells Cancer Research. 80: 631-631 |
Leonard BC, Lee ED, Bhola NE, et al. (2019) ATR inhibition sensitizes HPV and HPV head and neck squamous cell carcinoma to cisplatin. Oral Oncology. 95: 35-42 |
Chakrabarty A, Surendran S, Bhola NE, et al. (2019) The H1047R PIK3CA oncogene induces a senescence-like state, pleiotropy and acute HSP90 dependency in HER2+ mammary epithelial cells. Carcinogenesis |